Full Text (PDF)
Original Article

A Study on Immunohistochemical Expression of Ki-67 in Endometrial Hyperplasia and Endometrial Carcinoma

Shilpa T Patil. , Chittathur Vignesh1 , Shilpa T Patil2 , N Anusha3

Author Information

Licence:




Indian Journal of Pathology: Research and Practice 9(2 (Part-II)):p 21-26, May-August 2020. | DOI: http://dx.doi.org/10.21088/ijprp.2278.148X.9220.24

How Cite This Article:

Chittathur Vignesh, Shilpa T Patil, N Anusha. A Study on Immunohistochemical Expression of Ki-67 in
Endometrial Hyperplasia and Endometrial Carcinoma. Indian J Pathol Res Pract 2020;9(2 Part II):149–154.
 


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Background and Objective: Endometrial carcinoma is the most common gynaecologic malignancy in perimenopausal, and menopausal women. It is often preceded by endometrial hyperplasia. Estrogen appears to be involved in the development of endometrial carcinoma. Other mechanisms of endometrial carcinogenesis include mutations in
p53, PTEN, and proliferation markers like Ki-67. However, the pattern of Ki-67 expression is not well established in hyperplastic and neoplastic endometrium. Thus, objective of our study was to determine the immunohistochemical expression of Ki-67 in hyperplastic endometrium and endometrial carcinoma.


Methods: Immunohistochemical analysis of Ki-67 was done in 60 fixed, paraffin-embedded endometrial biopsy specimens and uterine resections obtained from patients. Specimens included simple hyperplasia, complex hyperplastic lesions, and endometrial adenocarcinoma.


Results: Ki-67 expression showed strong positivity in complex hyperplasia with atypia when compared to simple
hyperplasia, and complex hyperplasia without atypia. Though high grade endometrial carcinomas expressed more Ki-67 positivity, but there was no statistical significance found between expression of Ki-67 and tumour grading. Strong positivity was seen in advanced tumours with positive correlation between expression of Ki-67 and tumour stage.


Conclusion: Theexpression of Ki-67 may be used as diagnostic and prognostic marker in cases of endometrial carcinoma. Further studies with larger samples are needed to validate these findings.


Keywords: Endometrial Carcinoma; Immunohistochemistry; Ki-67.


Key Messages: Ki-67 expression was positive in 74.3% cases of endometrial hyperplasia. Statistical association  was observed between Ki-67 expression and simple hyperplasia, and between Ki-67 expression and complex hyperplasia with atypia. Ki-67 expression was positive in 80% cases of endometrial carcinoma. Statistical association was noted between tumor staging and Ki-67 exp
 


References

No records found.


About this article


Cite this article

Chittathur Vignesh, Shilpa T Patil, N Anusha. A Study on Immunohistochemical Expression of Ki-67 in
Endometrial Hyperplasia and Endometrial Carcinoma. Indian J Pathol Res Pract 2020;9(2 Part II):149–154.
 


Licence:




Received Accepted Published
N/A N/A N/A

DOI: http://dx.doi.org/10.21088/ijprp.2278.148X.9220.24

Keywords


Article Level Metrics

Last Updated

Sunday 12 July 2026, 14:54:24 (IST)


2018

Accesses

6
434
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share